Dr. Memmott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 West 12th Avenue
Columbus, OH 43210
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2018 - 2020
University of Arizona College of Medicine-PhoenixChief Residency, Internal Medicine, 2017 - 2018- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2014 - 2017
University of Cincinnati College of MedicineClass of 2012
Certifications & Licensure
OH State Medical License 2018 - 2026
AZ State Medical License 2017 - 2020
FL State Medical License 2017 - 2019
Clinical Trials
- Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer Start of enrollment: 2022 Jan 18
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsCTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
